Trial Profile
Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group, Dose Finding Phase II Clinical Trial to Evaluate Anti Rosacea Effect and Safety of PAC-14028 Cream (0.1%, 0.3%, 1.0%) in Rosacea Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2019
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors AmorePacific
- 10 Jan 2017 New trial record